Companies/Biovica International AB
Follow

Biovica International AB

Nasdaq First North GM Stockholm (Sweden)

Biovica is a biotech company which develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments.
Go to market

Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Media
Showing 3 of 4
View all
www.biovica.com
Current instruments
Type
Ticker
ISIN
SHARE
BIOVIC B
SE0008613731
Nasdaq First North GM Stockholm Sweden (SE)
Top
News
Biovica tecknar sitt andra avtal med ledande amerikansk vårdgivare
25 Sep 2023 - 08:00
Biovica signs second agreement with leading US healthcare provider
25 Sep 2023 - 08:00
Biovica signs US agreement with leading healthcare provider in Arizona
19 Sep 2023 - 09:00
Biovica tecknar USA-avtal med ledande vårdgivare i Arizona
19 Sep 2023 - 09:00
Delårsrapport 1 - maj-juli 2023/2024
06 Sep 2023 - 08:00
Q1 Interim Report May-July 2023/2024
06 Sep 2023 - 08:00
Announcement from Biovica International AB's annual general meeting
05 Sep 2023 - 13:00
Kommuniké från årsstämma i Biovica International AB
05 Sep 2023 - 13:00
Biovica announces the start of a DiviTum® TKa clinical trial
24 Aug 2023 - 10:30
Biovica annonserar starten av klinisk DiviTum® TKa-studie
24 Aug 2023 - 10:30
Notice of annual general meeting in Biovica International AB
04 Aug 2023 - 12:30
Kallelse till årsstämma i Biovica International AB
04 Aug 2023 - 12:30
Biovica signs US commercial agreement with Occum Health
31 Jul 2023 - 08:00
Biovica tecknar kommersiellt avtal i USA med Occum Health
31 Jul 2023 - 08:00
Biovica achieves PLA code for Medicare
21 Jul 2023 - 08:00
Biovica erhåller PLA-kod för Medicare
21 Jul 2023 - 08:00
Biovica International AB – Årsredovisning för verksamhetsåret 2022/2023 publicerad
30 Jun 2023 - 08:00
Biovica International AB – Annual report for the financial year 2022/2023 published
30 Jun 2023 - 08:00
Year-end report 2022/2023 - Commercial agreements signed in the US and Europe!
21 Jun 2023 - 08:00
Bokslutkommuniké 2022/2023 - Kommersiella avtal tecknade i USA och Europa!
21 Jun 2023 - 08:00
Biovica tecknar avtal med leverantörsnätverket Contigo Health ConfigureNet™
10 Jun 2023 - 08:30
Biovica signs provider contract with provider network Contigo Health ConfigureNet™
10 Jun 2023 - 08:30
DiviTum® TKa results to be presented at ASCO
01 Jun 2023 - 16:02
DiviTum® TKa-resultat presenteras på ASCO
01 Jun 2023 - 16:02
Biovica tecknar det första kommersiella avtalet för DiviTum® TKa i USA
17 May 2023 - 21:00
Biovica signs the first commercial agreement for DiviTum® TKa in US
17 May 2023 - 21:00
Kommuniké från extra bolagsstämma i Biovica International
17 May 2023 - 14:15
Announcement from Biovica International AB's extra general meeting
17 May 2023 - 14:15
Kallelse till extra bolagstämma i Biovica International AB
27 Apr 2023 - 14:30
Notice of extra general meeting in Biovica International AB
27 Apr 2023 - 14:30
Biovica ingår kommersiellt partnerskap för DiviTum® TKa i Italien
04 Apr 2023 - 08:00
Biovica establishes DiviTum® TKa commercialization partnership in Italy
04 Apr 2023 - 08:00
Biovica tecknar kommersiellt partneravtal för DiviTum® TKa för Nederländerna och Polen
28 Mar 2023 - 08:00
Biovica signs DiviTum® TKa commercial partner agreement for Dutch and Polish markets
28 Mar 2023 - 08:00
Delårsrapport 3 - november-januari 2022/2023
16 Mar 2023 - 08:00
Q3 Interim report November-January 2022/2023
16 Mar 2023 - 08:00
Valberedning för Biovica inför årsstämman 2023
13 Mar 2023 - 16:00
Nomination Committee for Biovica for the 2023 Annual General Meeting
13 Mar 2023 - 16:00
Biovica receives CLIA certification
08 Feb 2023 - 08:00
Biovica erhåller CLIA-certifiering
08 Feb 2023 - 08:00
1 2 3 4 5
Show

40

Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
BIOVIC B
SE0008613731
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Biovica International AB with ticker BIOVIC B
Status
Active
Currency
SEK
Segment
First North Premier
First trading date
29 Mar 2017
Private placement
Sign in to buy
Private placement
Sign in to buy
Rights issue
Sign in to buy
People
Anders Rylander
CEO
Lars Holmqvist
Chairman of the board
Maria Holmlund
Board member
Ulf Jungnelius
Board member
Henrik Osvald
Board member
Jesper Söderqvist
Board member
Anders Rylander
Board member
Annika Berg
Board member
Marie-Louise Fjällskog
Board member
Company Details
Sector
HEALTH CARE
Website
Address
Dag Hammarskjölds väg 54 B
Zip code
752 37
City/district
Uppsala
Country
Sweden (SE)
Phones
Email
[email protected]
Registration number
556774-6150
LEI code
549300VADE1VRR555N78
First trade date
29 Mar 2017
Registration date
03 Jan 2009
Short name
BIOVIC

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More